In the US, Astellas markets products in the areas of Immunology,
Urology, Anti-Infectives, Cardiovascular and Dermatology. For more
information about Astellas Pharma US, Inc., please visit our website at
1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC guidelines for the
management of patients with atrial fibrillation. Journal of the
American College of Cardiology. 2006;48(4):854-906.
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular Trends in Incidence
of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000,
and Implications on the Projections for Future Prevalence.
Forward-Looking Statement Disclaimer
Certain statements in this press release contain forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995 or forward-looking information under applicable Canadian
securities legislation that may not be based on historical fact, including
without limitation statements containing the words "believe", "may",
"plan", "will", "estimate", "continue", "anticipate", "intend", "expect"
and similar expressions. Such forward-looking statements or information
involve known and unknown risks, uncertainties and other factors that may
cause our actual results, events or developments, or industry results, to
be materially different from any future results, events or developments
expressed or implied by such forward-looking statements or information.
Such factors include, among others, our stage of development, lack of
product revenues, additional capital requirements, risk associated with the
completion of clinical trials and obtaining regulatory approval
|SOURCE Cardiome Pharma Corp.|
Copyright©2007 PR Newswire.
All rights reserved